MEDISCA News at Your Fingertips

Medisca removes potential allergens from topical products and provides essential BUD testing to support clients.

Medisca Announces Further Measures Reinforcing Its Commitment to a Transparent and Compliant Pharmaceutical Drug Supply Chain

MEDISCA, a global leader in the pharmaceutical compounding industry, is proud to announce a partnership with Ananda Health, the leading CBD provider to US independent pharmacies.

In a company announcement last month to all employees, MEDISCA announced that in order to optimize productivity and improve operations, the company will not renew the lease for their Las Vegas facility and will instead concentrate on maximizing efficiency in their Dallas and Plattsburg locations.

In compliance with a recent Drug Enforcement Administration (DEA) ruling, compounding industry leader MEDISCA has discontinued its product line containing synthetically derived CBD.

MEDISCA, a global leader in the personalized pharmaceutical industry, has announced that the revolutionary compounding technology, repurposed and optimized over a seven-year period, is available exclusively from MEDISCA, and, therefore, MEDISCA is actively taking steps to inform its competitors about MEDISCA’s expanding patent portfolio relating to its MAZ mixers.